Titre : Composés benzhydryliques

Composés benzhydryliques : Questions médicales fréquentes

Termes MeSH sélectionnés :

Gene Expression Profiling
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Composés benzhydryliques : Questions médicales les plus fréquentes", "headline": "Composés benzhydryliques : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Composés benzhydryliques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-14", "dateModified": "2025-03-09", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Composés benzhydryliques" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Dérivés du benzène", "url": "https://questionsmedicales.fr/mesh/D001555", "about": { "@type": "MedicalCondition", "name": "Dérivés du benzène", "code": { "@type": "MedicalCode", "code": "D001555", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Diphénhydramine", "alternateName": "Diphenhydramine", "url": "https://questionsmedicales.fr/mesh/D004155", "about": { "@type": "MedicalCondition", "name": "Diphénhydramine", "code": { "@type": "MedicalCode", "code": "D004155", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.115.250" } } }, { "@type": "MedicalWebPage", "name": "2,2'-Dichloro-4,4'-méthylènedianiline", "alternateName": "Methylenebis(chloroaniline)", "url": "https://questionsmedicales.fr/mesh/D008753", "about": { "@type": "MedicalCondition", "name": "2,2'-Dichloro-4,4'-méthylènedianiline", "code": { "@type": "MedicalCode", "code": "D008753", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.115.500" } } }, { "@type": "MedicalWebPage", "name": "Modafinil", "alternateName": "Modafinil", "url": "https://questionsmedicales.fr/mesh/D000077408", "about": { "@type": "MedicalCondition", "name": "Modafinil", "code": { "@type": "MedicalCode", "code": "D000077408", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.115.550" } } }, { "@type": "MedicalWebPage", "name": "Orphénadrine", "alternateName": "Orphenadrine", "url": "https://questionsmedicales.fr/mesh/D009966", "about": { "@type": "MedicalCondition", "name": "Orphénadrine", "code": { "@type": "MedicalCode", "code": "D009966", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.115.600" } } } ], "about": { "@type": "MedicalCondition", "name": "Composés benzhydryliques", "alternateName": "Benzhydryl Compounds", "code": { "@type": "MedicalCode", "code": "D001559", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Loyd V Allen", "url": "https://questionsmedicales.fr/author/Loyd%20V%20Allen", "affiliation": { "@type": "Organization", "name": "International Journal of Pharmaceutical Compounding. lallen@ijpc.com." } }, { "@type": "Person", "name": "Jonas Bresien", "url": "https://questionsmedicales.fr/author/Jonas%20Bresien", "affiliation": { "@type": "Organization", "name": "Institut für Chemie, Universität Rostock, Albert-Einstein-Str. 3a, 18059 Rostock, Germany. axel.schulz@uni-rostock.de." } }, { "@type": "Person", "name": "Jose M Goicoechea", "url": "https://questionsmedicales.fr/author/Jose%20M%20Goicoechea", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Alexander Hinz", "url": "https://questionsmedicales.fr/author/Alexander%20Hinz", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Moritz T Scharnhölz", "url": "https://questionsmedicales.fr/author/Moritz%20T%20Scharnh%C3%B6lz", "affiliation": { "@type": "Organization", "name": "" } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Expression Profile of Inflammation Response Genes and Potential Regulatory Mechanisms in Dilated Cardiomyopathy.", "datePublished": "2022-08-17", "url": "https://questionsmedicales.fr/article/36035223", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1155/2022/1051652" } }, { "@type": "ScholarlyArticle", "name": "An interferon-inducible signature of airway disease from blood gene expression profiling.", "datePublished": "2022-05-19", "url": "https://questionsmedicales.fr/article/34649980", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1183/13993003.00569-2021" } }, { "@type": "ScholarlyArticle", "name": "Genome-Wide Analysis and Expression Profiling of Glutathione Reductase Gene Family in Oat (", "datePublished": "2022-10-01", "url": "https://questionsmedicales.fr/article/36232950", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijms231911650" } }, { "@type": "ScholarlyArticle", "name": "Genome-Wide Analysis and Expression Profiling of the Phenylalanine Ammonia-Lyase Gene Family in", "datePublished": "2022-06-20", "url": "https://questionsmedicales.fr/article/35743276", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijms23126833" } }, { "@type": "ScholarlyArticle", "name": "Gene expression profiles and metabolic pathways responsible for male sterility in cybrid pummelo.", "datePublished": "2024-10-15", "url": "https://questionsmedicales.fr/article/39407042", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00299-024-03357-x" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés chimiques organiques", "item": "https://questionsmedicales.fr/mesh/D009930" }, { "@type": "ListItem", "position": 3, "name": "Hydrocarbures", "item": "https://questionsmedicales.fr/mesh/D006838" }, { "@type": "ListItem", "position": 4, "name": "Hydrocarbures cycliques", "item": "https://questionsmedicales.fr/mesh/D006844" }, { "@type": "ListItem", "position": 5, "name": "Hydrocarbures aromatiques", "item": "https://questionsmedicales.fr/mesh/D006841" }, { "@type": "ListItem", "position": 6, "name": "Dérivés du benzène", "item": "https://questionsmedicales.fr/mesh/D001555" }, { "@type": "ListItem", "position": 7, "name": "Composés benzhydryliques", "item": "https://questionsmedicales.fr/mesh/D001559" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Composés benzhydryliques - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Composés benzhydryliques", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-06", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Composés benzhydryliques", "description": "Comment diagnostiquer une intoxication aux composés benzhydryliques ?\nQuels tests sont utilisés pour évaluer l'exposition ?\nQuels symptômes indiquent une surdose ?\nComment différencier les effets des composés benzhydryliques ?\nQuels signes cliniques sont associés à ces composés ?", "url": "https://questionsmedicales.fr/mesh/D001559?mesh_terms=Gene+Expression+Profiling&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Composés benzhydryliques", "description": "Quels sont les symptômes courants d'une exposition ?\nPeut-on avoir des réactions cutanées ?\nQuels effets neurologiques peuvent se manifester ?\nY a-t-il des symptômes respiratoires associés ?\nLes symptômes varient-ils selon la dose ?", "url": "https://questionsmedicales.fr/mesh/D001559?mesh_terms=Gene+Expression+Profiling&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Composés benzhydryliques", "description": "Comment prévenir l'exposition aux composés benzhydryliques ?\nY a-t-il des formations recommandées ?\nQuels sont les conseils de stockage sécuritaire ?\nComment sensibiliser le personnel aux risques ?\nQuelles sont les réglementations à suivre ?", "url": "https://questionsmedicales.fr/mesh/D001559?mesh_terms=Gene+Expression+Profiling&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Composés benzhydryliques", "description": "Quel est le traitement principal en cas d'intoxication ?\nDes antidotes spécifiques existent-ils ?\nComment gérer les symptômes neurologiques ?\nQuelle est l'importance de l'hydratation ?\nQuand faut-il envisager une hospitalisation ?", "url": "https://questionsmedicales.fr/mesh/D001559?mesh_terms=Gene+Expression+Profiling&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Composés benzhydryliques", "description": "Quelles complications peuvent survenir après une exposition ?\nLes effets à long terme sont-ils possibles ?\nComment les complications sont-elles gérées ?\nY a-t-il des risques de cancer associés ?\nLes complications peuvent-elles être évitées ?", "url": "https://questionsmedicales.fr/mesh/D001559?mesh_terms=Gene+Expression+Profiling&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Composés benzhydryliques", "description": "Quels sont les principaux facteurs de risque d'exposition ?\nL'âge influence-t-il le risque d'effets ?\nLes antécédents médicaux jouent-ils un rôle ?\nLes conditions environnementales affectent-elles le risque ?\nLes habitudes de vie influencent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D001559?mesh_terms=Gene+Expression+Profiling&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une intoxication aux composés benzhydryliques ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'historique médical et des tests de laboratoire spécifiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'exposition ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des analyses sanguines et urinaires peuvent détecter la présence de ces composés." } }, { "@type": "Question", "name": "Quels symptômes indiquent une surdose ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent confusion, somnolence et troubles respiratoires." } }, { "@type": "Question", "name": "Comment différencier les effets des composés benzhydryliques ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Une évaluation clinique complète et l'historique des médicaments sont nécessaires." } }, { "@type": "Question", "name": "Quels signes cliniques sont associés à ces composés ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent des anomalies neurologiques et des troubles cardiovasculaires." } }, { "@type": "Question", "name": "Quels sont les symptômes courants d'une exposition ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des nausées, des vertiges et des maux de tête." } }, { "@type": "Question", "name": "Peut-on avoir des réactions cutanées ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des éruptions cutanées et des démangeaisons peuvent survenir." } }, { "@type": "Question", "name": "Quels effets neurologiques peuvent se manifester ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles de la coordination et des convulsions peuvent se produire." } }, { "@type": "Question", "name": "Y a-t-il des symptômes respiratoires associés ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des difficultés respiratoires et une respiration rapide peuvent apparaître." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon la dose ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la gravité des symptômes dépend de la dose et de la durée d'exposition." } }, { "@type": "Question", "name": "Comment prévenir l'exposition aux composés benzhydryliques ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des équipements de protection lors de la manipulation de ces substances." } }, { "@type": "Question", "name": "Y a-t-il des formations recommandées ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des formations sur la manipulation sécurisée des produits chimiques sont conseillées." } }, { "@type": "Question", "name": "Quels sont les conseils de stockage sécuritaire ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Stocker dans des contenants étiquetés et dans des zones bien ventilées." } }, { "@type": "Question", "name": "Comment sensibiliser le personnel aux risques ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Organiser des sessions d'information régulières sur les dangers des composés." } }, { "@type": "Question", "name": "Quelles sont les réglementations à suivre ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Respecter les réglementations locales et nationales sur la manipulation des produits chimiques." } }, { "@type": "Question", "name": "Quel est le traitement principal en cas d'intoxication ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement comprend l'administration de charbon actif et une surveillance médicale." } }, { "@type": "Question", "name": "Des antidotes spécifiques existent-ils ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas d'antidote spécifique pour les composés benzhydryliques." } }, { "@type": "Question", "name": "Comment gérer les symptômes neurologiques ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments anticonvulsivants peuvent être administrés pour contrôler les crises." } }, { "@type": "Question", "name": "Quelle est l'importance de l'hydratation ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "L'hydratation est cruciale pour aider à éliminer les toxines du corps." } }, { "@type": "Question", "name": "Quand faut-il envisager une hospitalisation ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "L'hospitalisation est nécessaire en cas de symptômes graves ou de complications." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après une exposition ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications neurologiques et respiratoires peuvent se développer." } }, { "@type": "Question", "name": "Les effets à long terme sont-ils possibles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des effets à long terme sur la santé peuvent survenir après une exposition prolongée." } }, { "@type": "Question", "name": "Comment les complications sont-elles gérées ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "La gestion des complications nécessite un suivi médical régulier et des traitements adaptés." } }, { "@type": "Question", "name": "Y a-t-il des risques de cancer associés ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études suggèrent un lien potentiel entre l'exposition et le cancer." } }, { "@type": "Question", "name": "Les complications peuvent-elles être évitées ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, en respectant les mesures de sécurité et en évitant l'exposition." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque d'exposition ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les travailleurs en laboratoire et ceux manipulant des produits chimiques sont à risque." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque d'effets ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les jeunes enfants et les personnes âgées sont plus vulnérables." } }, { "@type": "Question", "name": "Les antécédents médicaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de maladies respiratoires augmentent le risque." } }, { "@type": "Question", "name": "Les conditions environnementales affectent-elles le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une exposition dans des environnements mal ventilés augmente le risque." } }, { "@type": "Question", "name": "Les habitudes de vie influencent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme et l'alcoolisme peuvent exacerber les effets des composés." } } ] } ] }

Sources (10000 au total)

Expression Profile of Inflammation Response Genes and Potential Regulatory Mechanisms in Dilated Cardiomyopathy.

The inflammatory response is important in dilated cardiomyopathy (DCM). However, the expression of inflammatory response genes (IRGs) and regulatory mechanisms in DCM has not been well characterized.... We analyzed 27,665 cells of single-cell RNA sequencing dataset of four DCM samples and two healthy controls (HC). IRGs among differentially expressed genes (DEGs) of active cell clusters were screened... The proportions of dendritic cells (DCs), B cells, NK cells, and T cells were increased in DCM patients, whereas monocytes were decreased. DCs expressed more IRGs in DCM. The GO and KEGG analyses indi... DCs infiltrate into the myocardium and contribute to the immune response in DCM. The transcription factor ETS1 plays an important role in regulation of IRGs. Moreover,...

An interferon-inducible signature of airway disease from blood gene expression profiling.

The molecular basis of airway remodelling in chronic obstructive pulmonary disease (COPD) remains poorly understood. We identified gene expression signatures associated with chest computed tomography ... In 2396 subjects in the COPDGene Study, we examined the relationship between quantitative CT airway phenotypes and blood transcriptomes to identify airway disease-specific genes and to define an airwa... Type 1 interferon (IFN)-induced genes were consistently associated with AWT, square root wall area of a hypothetical airway with 10 mm internal perimeter (Pi10) and wall area percentage, with the stro... A gene expression signature with IFN-stimulated genes from peripheral blood and bronchial brushings is associated with CT AWT, lung function and exacerbations. Shared genes and genetic associations su...

Validation of the Prognostic Usefulness of the Gene Expression Profiling Test in Patients with Uveal Melanoma.

To validate the prognostic usefulness of gene expression profile (GEP) testing in patients with uveal melanoma. To determine whether combining tumor size with the GEP classification provides additiona... Retrospective analysis.... Patients with a diagnosis of choroidal melanoma examined at Yale New Haven Hospital; University of California, San Diego; and Memorial Sloan Kettering Cancer Center.... Patients' demographic and clinical data and tumor characteristics were collected. Univariate and multivariate Cox hazard regression analysis were used to assess the association between tumor character... Metastasis-free survival (MFS).... Of the 337 individuals included in the study, 87 demonstrated metastases. The mean follow-up time was 37.2 (standard deviation [SD], 40.2) months for patients with metastases and 55.0 (SD, 49.3) month... Tumor size was the most significant predictor of metastasis and provided additional prognostic value independent of GEP classification. In addition, rates of metastasis for class 2 tumors were lower t... The author(s) have no proprietary or commercial interest in any materials discussed in this article....

Autoimmune gene expression profiling of fingerstick whole blood in Chronic Fatigue Syndrome.

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a debilitating condition that can lead to severe impairment of physical, psychological, cognitive, social, and occupational functions. Th... In 2021, one-hundred and sixty-six (166) patients diagnosed with ME/CFS and 83 healthy controls in the US participated in this study via a social media-based application (app). The patients and heathy... Among the 166 ME/CFS participants in the study, approximately half (49%) of the ME/CFS patients reported being house-bound or bedridden due to severe symptoms of the disease. From the AIP testing, ME/... Our study indicates that gene expression biomarkers may be used in identifying or differentiating subsets of ME/CFS patients having different levels of disease severity. These gene targets may also re...